SCLEROSIS, SYSTEMIC
Clinical trials for SCLEROSIS, SYSTEMIC explained in plain language.
Never miss a new study
Get alerted when new SCLEROSIS, SYSTEMIC trials appear
Sign up with your email to follow new studies for SCLEROSIS, SYSTEMIC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Extended trial tests drug for rare, hardening skin disease
Disease control TerminatedThis study aimed to see if taking the drug HZN-825 for an additional 52 weeks was safe and effective for people with a severe form of scleroderma, a disease that hardens skin and can damage internal organs. It was an extension of a previous trial, enrolling 174 participants who h…
Matched conditions: SCLEROSIS, SYSTEMIC
Phase: PHASE2 • Sponsor: Amgen • Aim: Disease control
Last updated Apr 03, 2026 14:43 UTC
-
Drug trial tests new hope for Hard-to-Treat skin and lung disease
Disease control TerminatedThis trial tested an investigational drug called HZN-825 in adults with a severe form of systemic sclerosis, a disease that causes skin thickening and can damage the lungs. About 300 participants received either the drug or a placebo for one year to see if it could improve lung f…
Matched conditions: SCLEROSIS, SYSTEMIC
Phase: PHASE2 • Sponsor: Amgen • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC